Servier
keyboard_backspaceBack to Home
Contact
905 Rte de Saran
45520 Gidy
France
Directeur de développement Pharmaceutique
About us
As an independent international pharmaceutical group, Servier is committed to therapeutic progress for the benefit of patients.
Our ambition is to become a recognized, focused and innovative player in oncology, targeting cancers that are difficult to treat. That's why the Group devotes nearly 70% of its R&D budget to the development of innovative, targeted oncology therapies. In these fields, Servier focuses on a limited number of specific pathologies in which precise patient characterization makes it possible to offer a targeted therapeutic response, thanks to precision medicine.
Business offer
Bio-S is an "all-in-one" unit, from active ingredient to drug.
As Servier's biomanufacturing center, we will develop manufacturing processes and analytical methods, produce clinical batches of active ingredients and experimental biomedicines for clinical trials, and thus contribute to accelerating research for the benefit of patients.
Activities
- Research Unit
- Oncology
- Bioproduction
- Batches production type
- Mammalian
- Insect
- Yeast
- Bacterial
- GLP compliance
- GMP compliance
- Pilot Batches
- Tests
- Optimization
- Scale-Up process
- Process optimization & validation
- Volume
- Low volume (< 200 L)
- Formulation
- Formulation
- Dose
- Stability
- Excipients
- Adjuvants
- Sterilization
- Lyophilization
- Storage stability
- Delivery
- Route of Administration
- Devices associated
